New York State Common Retirement Fund Albireo Pharma, Inc. Transaction History

New York State Common Retirement Fund

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$18.01 - $23.78 $234 - $309	-13 Reduced 0.11%	11,751 $254,000
Q3 2022 Nov 08, 2022	SELL	$16.32 - $26.37 $260,108 - $420,285	-15,938 Reduced 57.53%	11,764 $228,000
Q2 2022 Aug 04, 2022	SELL	$18.54 - $37.29 $27,606 - $55,524	-1,489 Reduced 5.1%	27,702 $550,000
Q1 2022 May 05, 2022	BUY	$23.94 - $33.74 $417,776 - $588,796	17,451 Added 148.65%	29,191 $871,000
Q4 2021 Feb 02, 2022	SELL	$21.19 - $31.29 $741 - $1,095	-35 Reduced 0.3%	11,740 $273,000
Q3 2021 Nov 02, 2021	SELL	$27.36 - $35.98 $91,984 - $120,964	-3,362 Reduced 22.21%	11,775 $367,000
Q2 2021 Aug 02, 2021	BUY	$28.9 - $36.87 $3,959 - $5,051	137 Added 0.91%	15,137 $533,000
Q1 2021 May 11, 2021	BUY	$32.03 - $42.85 $44,842 - $59,990	1,400 Added 10.29%	15,000 $529,000
Q2 2020 Aug 07, 2020	BUY	$14.82 - $29.92 $50,388 - $101,728	3,400 Added 33.33%	13,600 $360,000
Q2 2018 Aug 10, 2018	BUY	$28.9 - $37.31 $294,780 - $380,562	10,200 New	10,200 $362,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.